Abstract:BackgroundOvarian cancer (OC) is the second most frequent gynecological cancer and is associated with a poor prognosis because OC progression is often asymptoma-tic and is detected at a late stage. There remains an urgent need for novel targeted therapies to improve clinical outcomes in ovarian cancer. As a nitric oxide prodrug, JS-K is reported highly cytotoxic to human cancer cells such as acute myeloid leukemia, multiple myeloma and breast cancer. This study is aim to investigate the influence of JS-K on proliferation and apoptosis in ovarian cancer cells and explored possible autophagy-related mechanisms, which will contribute to future ovarian cancer therapy and supply theory support that JS-K holds great promise as a novel therapeutic agent against ovarian cancer.MethodsThe cytotoxicity, extracellular ROS/RNS activity and apoptotic effect of JS-K and indicated inhibitors on ovarian cancer cells in vitro were evaluated by MTT assay, extracellular ROS/RNS assay, caspases activities assay and western blot. Further autophagy effect of JS-K and indicated inhibitors were examined by MTT assay, cell transfection, immunofluorescence analysis, transmission electron microscopy (TEM) analysis and western blot on ovarian cancer cells in vitro. In vivo, the BALB/c-nude female mice with SKOV3 ovarian cancer cells xenograft were used to examine the efficacy of JS-K treatment on tumor growth. PCNA and p62 proteins were analyzed by immunohistochemistry.ResultsIn vitro, JS-K inhibited the proliferation of ovarian cancer cells, induced apoptosis and cell nucleus shrinkage, enhanced the enzymatic activity of caspase-3/7/8/9, and significantly increased the production of ROS/RNS in ovarian cancer A2780 and SKOV3 cells, these effects were attenuated by inhibition of NAC. In addition, JS-K induced autophagy-related proteins and autophagosomes changes in ovarian cancer A2780 and SKOV3 cells. In vivo, JS-K inhibited tumor growth, decreased p62 protein expression and increased the expression levels of PCNA in xenograft models which were established using SKOV3 ovarian cancer cells.ConclusionTaken together, we demonstrated that ROS/RNS stress-mediated apoptosis and autophagy are mechanisms by which SKOV3 cells undergo cell death after treatment with JS-K in vitro. Moreover, JS-K inhibited SKOV3 tumor growth in vivo. An alternative therapeutic approach for triggering cell death in cancer cells could constitute a useful multimodal therapies for treating ovarian cancer, which is known for its resistance to apoptosis-inducing drugs.

Inhibition of JNK3 promotes apoptosis induced by BH3 mimetic S1 in chemoresistant human ovarian cancer cells.

The Bh3 Mimetic S1 Induces Endoplasmic Reticulum Stress-Associated Apoptosis In Cisplatin-Resistant Human Ovarian Cancer Cells Although It Activates Autophagy

SIRT3 Participates in Glucose Metabolism Interruption and Apoptosis Induced by BH3 Mimetic S1 in Ovarian Cancer Cells.

Caspase-mediated cleavage of Beclin1 inhibits autophagy and promotes apoptosis induced by S1 in human ovarian cancer SKOV3 cells

The BH3 Mimetic S1 Induces Autophagy Through ER Stress and Disruption of Bcl-2/Beclin 1 Interaction in Human Glioma U251 Cells

Cellular mechanisms of a new pyrazinone compound that induces apoptosis in SKOV-3 cells.

Clinicopathological and biological significance of aberrant activation of glycogen synthase kinase-3 in ovarian cancer.

Proapoptotic activity of JNK-sensitive BH3-only proteins underpins ovarian cancer response to replication checkpoint inhibitors

Smh-3 Induces G2/M Arrest and Apoptosis Through Calcium-Mediated Endoplasmic Reticulum Stress and Mitochondrial Signaling in Human Hepatocellular Carcinoma Hep3B Cells

Inhibition of SF3B1 Improves the Immune Microenvironment Through Pyroptosis and Synergizes with Αpdl1 in Ovarian Cancer.

BMH-21 Inhibits Viability and Induces Apoptosis by P53-Dependent Nucleolar Stress Responses in SKOV3 Ovarian Cancer Cells

JS-K, a Nitric Oxide Donor, Induces Autophagy As a Complementary Mechanism Inhibiting Ovarian Cancer

Research of Mechanism That Inhibitor of Bcl-2 S1 Induce SKOV3 Cell Apoptosis

A Diterpenoid Derivate Compound Targets Selenocysteine of Thioredoxin Reductases and Induces Bax/Bak-Independent Apoptosis

S1 kills MCF-7/ADR cells more than MCF-7 cells: A protective mechanism of endoplasmic reticulum stress.

Glycogen Synthase Kinase 3 Beta Induces Apoptosis In Cancer Cells Through Increase Of Survivin Nuclear Localization

Blocking NF-κB and Akt by Hsp90 Inhibition Sensitizes Smac Mimetic Compound 3-Induced Extrinsic Apoptosis Pathway and Results in Synergistic Cancer Cell Death.

Apoptosis Mechanism Induced by BH3 Mimetic S1 in Human Leukemia Cell Line K562

Proapoptotic Effect of Icariin on Human Ovarian Cancer Cells Via the NF-κB/PI3K-AKT Signaling Pathway: A Network Pharmacology-Directed Experimental Investigation

MHY2251, a New SIRT1 Inhibitor, Induces Apoptosis via JNK/p53 Pathway in HCT116 Human Colorectal Cancer Cells

SIRT1 induces resistance to apoptosis in human granulosa cells by activating the ERK pathway and inhibiting NF-κB signaling with anti-inflammatory functions